Kadence Bio

📍 London, United Kingdom🗓 Founded 2021👥 18 employees💰 Last funded Nov 2025
We are a clinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa.
6
Total investors
4
Early stage
2
Mid stage
0
Late stage
2021
Founded
Investor geography4 countries
United States
2
France
1
United Kingdom
1
Singapore
1
Investor activity2021–2025 · investors recorded per year
20211202232024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Kadence Bio?
Kadence Bio has 6 investors on record on gritt.io, including 4 early-stage backers, 2 mid-stage.
When did Kadence Bio last raise funding?
The most recent investment in Kadence Bio recorded on gritt.io was in November 2025.
When was Kadence Bio founded?
Kadence Bio was founded in 2021.
What industry is Kadence Bio in?
Kadence Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kadence Bio based?
Kadence Bio is headquartered in London, United Kingdom.